946 results on '"Ng, Leong L"'
Search Results
2. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
3. Proenkephalin as a biomarker correlates with acute kidney injury: a systematic review with meta-analysis and trial sequential analysis
4. Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease
5. Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure
6. Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF
7. Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure
8. Heart failure with normal LVEF in BIOSTAT-CHF
9. Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure
10. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
11. Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium
12. Punto de corte óptimo del antígeno carbohidrato 125 para la identificación de pacientes con bajo riesgo tras un ingreso por insuficiencia cardiaca aguda
13. An optimised method to isotopically label pure synthetic peptides 'in‐house' for absolute quantification in bottom‐up proteomics.
14. Use of Nonhuman Sera as a Highly Cost-Effective Internal Standard for Quantitation of Multiple Human Proteins Using Species-Specific Tryptic Peptides: Applicability in Clinical LC-MS Analyses
15. Short-term adverse remodeling progression in asymptomatic aortic stenosis
16. Abstract 12865: Is Atrial Fibrillation in HFpEF a Distinct Endotype? Insights From Multiparametric MRI and Circulating Fibroinflammatory Markers
17. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis
18. Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
19. Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF
20. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
21. Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF
22. Dysglycaemia and South Asian ethnicity: a proteomic discovery and confirmation analysis highlights differences in ZAG
23. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
24. Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study
25. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction
26. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
27. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
28. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
29. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
30. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?
31. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF
32. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study
33. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
34. Impact of diabetes on remodelling, microvascular function and exercise capacity in aortic stenosis
35. Effect of the 2017 European Guidelines on Reclassification of Severe Aortic Stenosis and Its Influence on Management Decisions for Initially Asymptomatic Aortic Stenosis
36. Differential implications of gut-related metabolites on outcomes between heart failure and myocardial infarction.
37. Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D
38. Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration: Potential Relevance to COVID-19 Risk
39. Exon Repetition in mRNA
40. The Edge Effect in High-Throughput Proteomics: A Cautionary Tale
41. Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
42. Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure
43. Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction
44. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure
45. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
46. Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome
47. Prognostic Significance of Adrenomedullin in Patients With Heart Failure and With Myocardial Infarction
48. Plasma desmosine for prediction of outcomes after acute myocardial infarction
49. Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use
50. Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.